Robert A. Winn Diversity in Clinical Trials Award Program

The Future of Diversity in Clinical Trials

Meet some of the first cohort of diverse medical students dedicated to improving health equity who have been chosen to participate in the Robert A. Winn Clinical Investigator Pathway Program.
Article

When he was 11 years old, Cesar Ramirez contracted a joint infection that spread throughout his body. During a three-month stay in the hospital, his two physicians became not only his healers but also his inspiration. Today, the second-year medical student is pursuing the dream forged by that experience: a career in medicine. The son of Honduran immigrants, Ramirez is one of 44 diverse medical students dedicated to improving health equity who have been chosen to participate in the Robert A.

Gilead Sciences Announces Support for the Robert A. Winn Diversity in Clinical Trials Award Program

Multimedia with summary

Today we announced our support of the Robert A. Winn Diversity in Clinical Trials Award Program, a five-year initiative launched by the Bristol Myers Squibb Foundation to increase diversity in clinical trials. 

Bristol Myers Squibb Foundation Honors Diversity and Health Equity Leader By Naming Diversity in Clinical Trials Training Program After Him; Welcomes Gilead Sciences as Program Supporter

The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Press Release

PRINCETON, N.J., April 11, 2022/3BL Media/ - The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced a new name for the $100 million,

Subscribe to Robert A. Winn Diversity in Clinical Trials Award Program